We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.



80+ Mutants From SARS-CoV-2 Variants of Concern

80+ Mutants From SARS-CoV-2 Variants of Concern

After the sharp rise in COVID-19 cases and deaths in India over recent weeks, at least 20 countries have imposed travel bans and restrictions to and from India. The world again stands at a crossroad of the viral evolution.

Some preliminary studies yield necessary findings that may help prevent massive transmission of the variant. Certainly, to introduce appropriate public health interventions in the future, continuous genomic surveillance is needed to monitor the mutations on B.1.617 and other emerging variants of SARS-CoV-2.

ACROBiosystems has accelerated the development of a series of recombinant antigens of the SARS-CoV-2 Variants of Concern, including B.1.617, accordingly to help better understand the transmissibility and infectivity of the variant.

Featured Products
All critical mutations covered

  • Full length S trimer with multiple mutations
  • 6P and 2A mutations make the protein more stable
  • Suitable for antibody detection

    Relevant recommendation
    Broad-spectrum neutralizing antibody

    It is exciting that an anti-SARS-CoV-2 Spike RBD neutralizing antibody (Cat. No. S1N-M122) developed by ACROBiosystems retains potent neutralizing activity against popular SARS-CoV-2 variants as tested by pseudovirus assay. The broad-spectrum neutralizing antibody is suitable to be a positive control in neutralization antibody screening, QC test reagent for both recombinant protein vaccines and COVID-19 neutralizing antibody detection in vaccinated serum.

      About ACROBiosystems
      ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine. Our way of addressing challenges in biologics development is to offer a comprehensive array of tools and solutions designed for each development phase. Starting from discovery and development and moving beyond commercialization, we strive to deliver high-quality solutions that support each step of the development process. This means bringing together innovation and technology through product development and collaborations to help our customers achieve translatable results in the clinic and beyond.
      Interested in seeing more content from ACROBiosystems ?
      Discover all their latest news, webinars, products and more by clicking the link below.